Imagine if you could shorten your trial start-up time, save about 50% on your trial costs, and access a market with a 50-million population with universal health coverage
Shorten trial start-up. Lower your costs. Recruit more patients, faster. Sell your product. All in Colombia!
- Fast approval at the MoH (after IRB approval): 30 days for medical devices and 60 days for pharma and biotech.
- Savings: Save about 50% on your clinical trial costs.
- Easier patient recruitment: Population of 50 million with universal healthcare coverage and unparalleled patient pool.